p53 induces angiogenesis-restricted dormancy in a mouse fibrosarcoma

Area of Science:

• Oncology
• Molecular Biology
• Cancer Genetics

Background:

• The p53 tumor-suppressor gene is frequently inactivated in human cancers.
• p53 normally induces apoptosis and cell cycle arrest in response to DNA damage.

Purpose of the Study:

• To investigate the tumor-suppressive role of p53 independent of its effects on proliferation and apoptosis.
• To explore p53's impact on tumor angiogenesis and its therapeutic potential.

Main Methods:

• Utilized a murine fibrosarcoma cell line.
• Assessed p53's effect on target gene activation, cell cycle progression, and survival.
• Evaluated the impact of exogenous wild-type p53 (wt-p53) on tumor cell angiogenic potential in vivo.
• Observed tumor formation and dormancy in vivo.

Main Results:

• p53 activated target genes in tumor cells without affecting cell cycle progression or survival in vitro.
• Exogenous wt-p53 expression blocked tumor cell angiogenic potential.
• Tumor cells expressing wt-p53 formed dormant tumors in vivo.
• p53 inhibition of angiogenesis indirectly induced apoptosis in vivo, but not in vitro.

Conclusions:

• p53 functions as a tumor suppressor independently of its anti-proliferative effects.
• p53 inhibits tumor growth by suppressing angiogenesis, which can indirectly lead to apoptosis.
• p53-based gene therapy targeting angiogenesis may revert tumors to a dormant state.